<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Mol Genet Genomic Med</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol Genet Genomic Med</journal-id>
<journal-id journal-id-type="doi">10.1002/(ISSN)2324-9269</journal-id>
<journal-id journal-id-type="publisher-id">MGG3</journal-id>
<journal-title-group>
<journal-title>Molecular Genetics &amp; Genomic Medicine</journal-title>
</journal-title-group>
<issn pub-type="epub">2324-9269</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31628733</article-id>
<article-id pub-id-type="pmc">6900373</article-id>
<article-id pub-id-type="doi">10.1002/mgg3.1006</article-id>
<article-id pub-id-type="publisher-id">MGG31006</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Clinical Report</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Clinical Reports</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>De novo splice site variant of <italic>ARID1B</italic> associated with pathogenesis of Coffin–Siris syndrome</article-title>
<alt-title alt-title-type="left-running-head">PRANCKĖNIENĖ et al.</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" id="mgg31006-cr-0001">
<name>
<surname>Pranckėnienė</surname>
<given-names>Laura</given-names>
</name>
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0002-7442-0732</contrib-id>
<xref ref-type="aff" rid="mgg31006-aff-0001">
<sup>1</sup>
</xref>
<address>
<email>Laura.pranckeniene@mf.vu.lt</email>
</address>
</contrib>
<contrib contrib-type="author" corresp="yes" id="mgg31006-cr-0002">
<name>
<surname>Siavrienė</surname>
<given-names>Evelina</given-names>
</name>
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0003-3110-4059</contrib-id>
<xref ref-type="aff" rid="mgg31006-aff-0001">
<sup>1</sup>
</xref>
<address>
<email>Evelina.Siavriene@mf.vu.lt</email>
</address>
</contrib>
<contrib contrib-type="author" id="mgg31006-cr-0003">
<name>
<surname>Gueneau</surname>
<given-names>Lucie</given-names>
</name>
<xref ref-type="aff" rid="mgg31006-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mgg31006-cr-0004">
<name>
<surname>Preikšaitienė</surname>
<given-names>Eglė</given-names>
</name>
<xref ref-type="aff" rid="mgg31006-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mgg31006-cr-0005">
<name>
<surname>Mikštienė</surname>
<given-names>Violeta</given-names>
</name>
<xref ref-type="aff" rid="mgg31006-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mgg31006-cr-0006">
<name>
<surname>Reymond</surname>
<given-names>Alexandre</given-names>
</name>
<xref ref-type="aff" rid="mgg31006-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mgg31006-cr-0007">
<name>
<surname>Kučinskas</surname>
<given-names>Vaidutis</given-names>
</name>
<xref ref-type="aff" rid="mgg31006-aff-0001">
<sup>1</sup>
</xref>
</contrib>
</contrib-group>
<aff id="mgg31006-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Department of Human and Medical Genetics</named-content>
<named-content content-type="organisation-division">Institute of Biomedical Sciences</named-content>
<institution>Faculty of Medicine</institution>
<institution>Vilnius University</institution>
<city>Vilnius</city>
<country country="LT">Lithuania</country>
</aff>
<aff id="mgg31006-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Centre for Integrative Genomics</named-content>
<institution>University of Lausanne</institution>
<city>Lausanne</city>
<country country="CH">Switzerland</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break></break>
Laura Pranckėnienė and Evelina Siavrienė, Department of Human and Medical Genetics, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.<break></break>
Email: <email>Laura.pranckeniene@mf.vu.lt</email> (L. P.) and <email>Evelina.Siavriene@mf.vu.lt</email> (E. S.)<break></break></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>19</day>
<month>10</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<month>12</month>
<year>2019</year>
</pub-date>
<volume>7</volume>
<issue>12</issue>
<issue-id pub-id-type="doi">10.1002/mgg3.v7.12</issue-id>
<elocation-id>e1006</elocation-id>
<history>
<date date-type="received">
<day>15</day>
<month>7</month>
<year>2019</year>
</date>
<date date-type="rev-recd">
<day>06</day>
<month>9</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>18</day>
<month>9</month>
<year>2019</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2019 John Wiley & Sons Ltd. <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2019 The Authors. <italic>Molecular Genetics &amp; Genomic Medicine</italic> published by Wiley Periodicals, Inc.</copyright-statement>
<license license-type="creativeCommonsBy-nc-nd">
<license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="file:MGG3-7-e1006.pdf"></self-uri>
<abstract id="mgg31006-abs-0001">
<title>Abstract</title>
<sec id="mgg31006-sec-0001">
<title>Background</title>
<p>Coffin–Siris syndrome is an extremely rare syndrome associated with developmental and congenital anomalies. It is caused by heterozygous pathogenic variants of <italic>ARID1A</italic>, <italic>ARID1B</italic>, <italic>SMARCA4</italic>, <italic>SMARCB1</italic>, <italic>SMARCE1</italic>, and <italic>SOX11</italic>.</p>
</sec>
<sec id="mgg31006-sec-0002">
<title>Methods</title>
<p>This case study presents the whole exome sequencing of a patient with characteristic clinical features of Coffin–Siris syndrome. Analysis included Sanger sequencing of complementary DNA and bioinformatic analysis of the variant.</p>
</sec>
<sec id="mgg31006-sec-0003">
<title>Results</title>
<p>Analysis of cDNA Sanger sequencing data revealed that the donor splice site variant led to skipping of exon 19. Further, bioinformatic analysis predicted abnormal splicing in a translational frameshift of 11 amino acids and the creation of a premature termination codon. Results found a novel de novo splice site variant c.5025+2T&gt;C in the <italic>ARID1B</italic> and truncated 1 633 amino acid protein NP_065783.3:p. (Thr1633Valfs*11).</p>
</sec>
<sec id="mgg31006-sec-0004">
<title>Conclusion</title>
<p>Truncated ARID1B resulted in loss of the BAF250 domain, which is part of SWI/SNF‐like ATP‐dependent chromatin remodeling complex. The severe clinical manifestation presented by the proband was attributed to the disappearance of the BAF250 domain in the ARID1B protein. Our finding provides strong evidence that this pathogenic variant of exon 19 caused a frameshift mutation in the <italic>ARID1B</italic> at the terminal exon, resulting in the expression of a severe phenotype of CSS.</p>
</sec>
</abstract>
<abstract abstract-type="graphical" id="mgg31006-abs-0002">
<p>This case study examined the whole exome sequencing of a patient with characteristic clinical features of Coffin–Siris syndrome and found a novel de novo splice site variant c.5025+2T&gt;C in the <italic>ARID1B</italic>. Analysis of cDNA Sanger sequencing data obtained from this patient revealed that the donor splice site variant led to skipping of exon 19. The severe clinical manifestation that our proband presented with; cumulated in disappearance of the BAF250 domain in the ARID1B protein. Thus, providing strong evidence that this pathogenic variant of exon 19 caused frameshift mutation in the <italic>ARID1B</italic> at the terminal exon resulting in the expression of a severe phenotype of CSS.<boxed-text content-type="graphic" id="mgg31006-blkfxd-0001" orientation="portrait" position="anchor"><graphic id="nlm-graphic-1" orientation="portrait" position="anchor" xlink:href="MGG3-7-e1006-g003.jpg"></graphic></boxed-text>
</p>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="mgg31006-kwd-0001">
<styled-content style="fixed-case" toggle="no">
<italic>ARID1B</italic>
</styled-content>
</kwd>
<kwd id="mgg31006-kwd-0002">cDNA functional analysis</kwd>
<kwd id="mgg31006-kwd-0003">Coffin–Siris syndrome</kwd>
<kwd id="mgg31006-kwd-0004">de novo splice site variant</kwd>
<kwd id="mgg31006-kwd-0005">intellectual disability</kwd>
<kwd id="mgg31006-kwd-0006">skipping of exon 19</kwd>
<kwd id="mgg31006-kwd-0007">WES</kwd>
</kwd-group>
<funding-group>
<award-group id="funding-0001">
<funding-source>INGENES project</funding-source>
<award-id>S‐MIP‐17‐19/LSS‐150000‐1179</award-id>
</award-group>
<award-group id="funding-0002">
<funding-source>Lithuanian‐Swiss Cooperation Program under UNIGENE Project</funding-source>
<award-id>CH‐3‐ŠMM‐01/04</award-id>
</award-group>
<award-group id="funding-0003">
<funding-source>
<institution-wrap>
<institution>Research Council of Lithuania </institution>
<institution-id institution-id-type="open-funder-registry">10.13039/501100004504</institution-id>
</institution-wrap>
</funding-source>
</award-group>
</funding-group>
<counts>
<fig-count count="2"></fig-count>
<table-count count="0"></table-count>
<page-count count="6"></page-count>
<word-count count="3715"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>December 2019</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.7.2 mode:remove_FC converted:08.12.2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<p content-type="self-citation">
<mixed-citation id="mgg31006-cit-1001" publication-type="journal">
<string-name>
<surname>Pranckėnienė</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Siavrienė</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Gueneau</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>De novo splice site variant of <styled-content style="fixed-case" toggle="no"><italic>ARID1B</italic></styled-content> associated with pathogenesis of Coffin–Siris syndrome</article-title>. <source xml:lang="en"/>Mol Genet Genomic Med. <year>2019</year>;<volume>7</volume>:<elocation-id>e1006</elocation-id>
<pub-id pub-id-type="doi">10.1002/mgg3.1006</pub-id>
</mixed-citation>
</p>
<fn-group id="mgg31006-ntgp-0001">
<fn fn-type="funding" id="mgg31006-note-0001">
<p>
<bold>Funding information</bold>
</p>
<p>This study was supported by the Lithuanian‐Swiss Cooperation Program under UNIGENE Project agreement no. CH‐3‐ŠMM‐01/04 and by a grant from the Research Council of Lithuania under INGENES project no. S‐MIP‐17‐19/LSS‐150000‐1179.</p>
</fn>
</fn-group>
</notes>
</front>
<body id="mgg31006-body-0001">
<sec id="mgg31006-sec-0005">
<label>1</label>
<title>INTRODUCTION</title>
<p>Intellectual disability (ID) affects about 1–3% of the general population worldwide and is the most prevalent type of severe brain disorder. Evaluation of the genetic causes of ID remains challenging as the condition is clinically and genetically heterogeneous. ID can occur as an isolated condition, a variety of congenital anomalies, or other clinical symptoms as part of a syndrome. More than 60 structural variants and over 700 genes have been proposed to cause ID; however, many of the genes associated with ID remain unidentified.</p>
<p>One of the genes associated with ID is <italic>ARID1B</italic> (MIM #614556) (Hoyer et al., <xref ref-type="ref" rid="mgg31006-bib-0009">2012</xref>; Santen et al., <xref ref-type="ref" rid="mgg31006-bib-0014">2012</xref>). In 2012, Hoyer et al. discovered that the <italic>ARID1B</italic> was directly involved in the pathogenesis of unexplained ID cases, based on their finding of a heterozygous 2.5 Mb deletion (Hoyer et al., <xref ref-type="ref" rid="mgg31006-bib-0009">2012</xref>). Furthermore, in 2018, Bögershausen et al. conducted a candidate gene study on 887 patients with unexplained ID and isolated eight <italic>ARID1B</italic> variants (Bögershausen &amp; Wollnik, <xref ref-type="ref" rid="mgg31006-bib-0003">2018</xref>). Since this study, <italic>ARID1B</italic> has been found to be the most frequently mutated gene in patients with ID. The <italic>ARID1B</italic> associated phenotypes range from nonsyndromic ID to Coffin–Siris syndrome (MIM #135900, CSS). According to a recent study of 143 patients with pathogenic variants of the <italic>ARID1B</italic>, ARID1B‐related disorders encompass a spectrum of features, including feeding difficulties, laryngomalacia, speech delay, motor delay, hypertrichosis, and cryptorchidism [PMID:30696996] (van der Sluijs et al., <xref ref-type="ref" rid="mgg31006-bib-0018">2018</xref>).</p>
<sec id="mgg31006-sec-0006">
<label>1.1</label>
<title>Case study</title>
<p>Here, we report a case of a patient with the clinical features of CSS caused by a previously undescribed de novo splice site variant detected by whole exome sequencing (WES) in the <italic>ARID1B</italic> and provided a functional evaluation of its effect on pre‐mRNA splicing.</p>
<p>The patient was a 13‐year‐ old female born to non‐consanguineous Lithuanian parents. She was born following an uncomplicated pregnancy at 37 weeks of gestation via spontaneous vaginal delivery. Her birth weight was 2,200 g (3–10 centile) and Apgar scores at 1 and 5 min were 7 and 7, respectively. The newborn was sluggish, with low muscle tone and remained in the neonatal intensive care unit a few days after birth. Psychomotor delay was noted from infancy. When the infant was 16 months old, she was assessed according to the DISC scale, and her psychomotor development was evaluated at the range of 4 (gross motor) to 9 (auditory attention and memory) months. She could sit independently at 2 years and walk unassisted at 3 years. Brain CT at age 6 revealed an abnormal configuration of the ventricles, agenesis of the corpus callosum, and hypoplasia of the superior part of the left cerebellar hemisphere. EEG was normal. The proband exhibited extreme myopia (−23 in OD and −22 in OS) and myopic macular degenerative changes. An echocardiogram at the age of 8 denoted aortic valve insufficiency and mitral valve prolapse. Additional testing such as abdominal ultrasound, hearing examination, and endocrinological evaluation appeared normal. However, the proband experienced frequent recurrent infections. During her final examination at the age of 13 years and 10 months, her head circumference was 54 cm (25–50 centile), height was 145 cm (&lt;3rd centile), and weight was 50.5 kg (50th centile). She presented with coarse facial features, low forehead, wide and thick eyebrows, long eyelashes, prominent ears, opened mouth, thick lower lip, sialorrhea, limited extension of the elbows, hypermobile small joints, brachydactyly, clinodactyly of the fifth finger, small nails, flat feet, one café au lait spot, sparse and rough scalp hair, hirsutism, as well as obesity (Figure <xref ref-type="fig" rid="mgg31006-fig-0001">1</xref>a–f). Her gait was unstable, she was recently toilet‐trained, mute, and her ID was severe (IQ 23).</p>
<fig fig-type="Figure" id="mgg31006-fig-0001" orientation="portrait" position="float" xml:lang="en">
<label>Figure 1</label>
<caption>
<p>(a–b) Front and side facial views of the patient at 7 years of age. (c–f) Front and side facial views as well as the hands of the patient at the age of 13 years</p>
</caption>
<graphic id="nlm-graphic-3" xlink:href="MGG3-7-e1006-g001"></graphic>
</fig>
<p>As no cytogenetic alterations were identified, WES of the proband and her healthy parents was performed.</p>
</sec>
</sec>
<sec id="mgg31006-sec-0007" sec-type="methods">
<label>2</label>
<title>METHODS</title>
<sec id="mgg31006-sec-0008">
<label>2.1</label>
<title>Whole exome sequencing</title>
<p>Genomic DNA (gDNA) was extracted from the peripheral blood lymphocytes using a phenol–chloroform extraction method. The WES was performed using a protocol that we have previously utilized successfully to identify the potential cause of this Mendelian trait disease (Alfaiz et al., <xref ref-type="ref" rid="mgg31006-bib-0001">2014</xref>; Borck et al., <xref ref-type="ref" rid="mgg31006-bib-0004">2015</xref>; Gueneau et al., <xref ref-type="ref" rid="mgg31006-bib-0007">2018</xref>; Lodder et al., <xref ref-type="ref" rid="mgg31006-bib-0012">2016</xref>; Tumienė et al., <xref ref-type="ref" rid="mgg31006-bib-0016">2017</xref>). Briefly, exomes were captured using the Agilent SureSelect Human All Exon V5 enrichment kit (Agilent), and multiplex sequenced (6‐plex) on an Illumina HiSeq 2,500 (Illumina, Inc.) platform to reach about 100‐fold coverage. Resultant reads were mapped to the human reference genome UCSC genome browser build 38. Variants and small indels (up to 20 bp) were called using GATK <italic>v.3</italic> analysis pipeline (Van der Auwera et al., <xref ref-type="ref" rid="mgg31006-bib-0017">2013</xref>). BAM‐formatted files of the mother, father, and child were combined using Samtools software. De novo variants were identified by VarScan software. A potential variant was deemed to be de novo if it was identified in the offspring but not present in either parent at the same position. Parameters used for the filtration of false‐positive variants were described previously by Pranckėnienė et al. (Pranckeniene, Jakaitiene, Ambrozaityte, Kavaliauskiene, &amp; Kučinskas, <xref ref-type="ref" rid="mgg31006-bib-0013">2018</xref>). All filtered and manually reviewed, de novo variants were annotated using ANNOVAR. Sanger sequencing of <italic>ARID1B</italic> coding region was amplified via polymerase chain reaction (PCR) with primer sets listed in Table <xref ref-type="supplementary-material" rid="mgg31006-sup-0001">S1</xref>. The resulting PCR product was purified and sequenced using BigDye Terminator kit v3.1 (Applied Biosystems) and ABI PRISM 3130xl Genetic Analyzer (Applied Biosystems). The resulting sequence was aligned with the <italic>ARID1B</italic> reference sequence (GenBank NCBI: NM_020732.3) using Nucleotide Blast toolkit, Mutation Taster (<ext-link ext-link-type="uri" xlink:href="://www.mutationtaster.org/">://www.mutationtaster.org/</ext-link>), and Human Splicing Finder (<ext-link ext-link-type="uri" xlink:href="://www.umd.be/HSF3/">://www.umd.be/HSF3/</ext-link>) databases were used for predicting splice site alterations. Potential variants in the ARID1B protein (UniProtKB: Q8NFD5) were predicted using ExPASy Bioinformatics Resource Portal (<ext-link ext-link-type="uri" xlink:href="://www.expasy.org/">://www.expasy.org/</ext-link>) and Pfam 32.0 database (<ext-link ext-link-type="uri" xlink:href="://pfam.xfam.org/">://pfam.xfam.org/</ext-link>).</p>
</sec>
<sec id="mgg31006-sec-0009">
<label>2.2</label>
<title>Functional analysis of cDNA</title>
<p>Total RNA of the proband was isolated from whole blood using a Tempus™ Blood RNA Tube and Tempus™ Spin RNA Isolation Kit (Thermo Fisher Scientific). Complementary DNA (cDNA) was synthesized from total RNA using a High‐Capacity RNA‐to‐cDNA Kit (Thermo Fisher Scientific). PCR of cDNA sequence flanking donor splice site variant of <italic>ARID1B</italic> was performed using specific primers designed with Primer Blast (<ext-link ext-link-type="uri" xlink:href="://www.ncbi.nlm.nih.gov/tools/primer-blast/">://www.ncbi.nlm.nih.gov/tools/primer-blast/</ext-link>) software. The designed primer pairs are listed in Table <xref ref-type="supplementary-material" rid="mgg31006-sup-0001">S1</xref>. In order to elucidate the pathogenicity of the detected variant, functional analysis using the proband's cDNA amplicon was performed. PCR products were sequenced using standard Sanger sequencing technique as indicated above. The resulting partially overlapping sequence was manually aligned with the reference sequence of the <italic>ARID1B</italic> (NCBI: NM_020732.3).</p>
</sec>
</sec>
<sec id="mgg31006-sec-0010" sec-type="results">
<label>3</label>
<title>RESULTS</title>
<p>A de novo 5′ splice site NC_000006.12 (NM_020732.3):c.5025+2T&gt;C variant in intron 19 of <italic>ARID1B</italic> was identified. However, data on the frequency of this variant are currently unavailable in the ExAC database. The donor splice site variant was confirmed by Sanger sequencing (Figure <xref ref-type="fig" rid="mgg31006-fig-0002">2</xref>a). Segregation analysis of gDNA in the samples of the proband and her parents confirmed a de novo origin of the variant (Figure <xref ref-type="fig" rid="mgg31006-fig-0002">2</xref>a). Moreover, all of the unique de novo variants for this proband are listed in Table <xref ref-type="supplementary-material" rid="mgg31006-sup-0001">S1</xref>.</p>
<fig fig-type="Figure" id="mgg31006-fig-0002" orientation="portrait" position="float" xml:lang="en">
<label>Figure 2</label>
<caption>
<p>(a) Electropherogram of the gDNA sequence of the patient showed a de novo substitution in <italic>ARID1B</italic>: 5025+2T&gt;C. (b) Schematic representation of <italic>ARID1B</italic> reference and mutant sequence with NM_020732.3: c.5025+2T&gt;C variant, denoted skipping of exon 19. (c) Sanger sequencing of proband's cDNA sample reverse strand. (d) Schematic view of truncated ARID1B protein according to the Pfam protein domain database. ARID domain is indicated with a green square, while BAF250_C, which is lost due to the splice site variant in <italic>ARID1B</italic>, is represented with a red square</p>
</caption>
<graphic id="nlm-graphic-5" xlink:href="MGG3-7-e1006-g002"></graphic>
</fig>
<p>The identified 5′ splice site variant was predicted to be “probably pathogenic” utilizing bioinformatics tools. Sanger sequencing of the proband's cDNA sample was performed in order to validate these findings. The analysis of the <italic>ARID1B</italic> coding sequence revealed that the donor splice site variant led to skipping of exon 19 (131 bp in length). In further bioinformatic analysis, the abnormal splicing was predicted to result in a translational frameshift of 11 amino acids and the formation of a premature termination codon, thereby resulting in truncated 1,633 amino acid protein NP_065783.3:p.(Thr1633Valfs*11) (Figure <xref ref-type="fig" rid="mgg31006-fig-0002">2</xref>).</p>
</sec>
<sec id="mgg31006-sec-0011" sec-type="discussion">
<label>4</label>
<title>DISCUSSION</title>
<p>The main clinical signs presented by our patient were characteristic of Coffin–Siris syndrome, including ID, severe speech impairment, corpus callosum agenesis, growth deficiency, coarse facial features, <italic>myopia</italic>, and hypertrichosis. Heterozygous pathogenic variants in one or more genes among <italic>ARID1A</italic>, <italic>ARID1B</italic>, <italic>SMARCA4</italic>, <italic>SMARCB1</italic>, <italic>SMARCE1</italic>, and <italic>SOX11</italic> could be the cause of this syndrome. Due to the genetic heterogeneity of this disorder next generation sequencing has become the preferred method to identify underlying genetic causes in patients with ID. WES analysis of our patient revealed a novel de novo splice site variant in the <italic>ARID1B</italic>, confirming the clinical diagnosis of Coffin–Siris syndrome.</p>
<p>Recent studies of previously identified variants found human Brahma‐associated factor (BAF) chromatin remodeling components in individuals with autism spectrum disorder (ASD) and ID. This finding provided strong evidence that the <italic>ARID1B</italic> created a link between chromatin remodeling and neurodevelopmental disorders. BAF is an ATP‐dependent chromatin remodeling complex that controls gene expression by facilitating DNA access for transcription factors (Jung et al., <xref ref-type="ref" rid="mgg31006-bib-0010">2017</xref>). ARID1, which is the largest subunit of the BAF complex, is expressed as two isoforms: ARID1A and ARID1B (Vasileiou et al., <xref ref-type="ref" rid="mgg31006-bib-0019">2015</xref>). According to the GTEx portal, <italic>ARID1B</italic> is widely expressed in the skin, thyroid, ovaries, bladder, and whole blood. Elevated expression of this gene has also been detected in the human brain and mammalian embryonic stem cells. Thus, the heterogeneous nature of this gene could explain the vast array of phenotypic variability found in ID patients with mutations of the BAF complex (Santen et al., <xref ref-type="ref" rid="mgg31006-bib-0015">2013</xref>; Wieczorek et al., <xref ref-type="ref" rid="mgg31006-bib-0020">2013</xref>).</p>
<p>To date LOVD <italic>ARID1B</italic> database (<ext-link ext-link-type="uri" xlink:href="://databases.lovd.nl/shared/variants/ARID1B">://databases.lovd.nl/shared/variants/ARID1B</ext-link>; accessed 10 December 2018) contained 153 pathogenic or likely pathogenic variants, 19 of which were in noncoding regions. The majority of variants in the <italic>ARID</italic> family genes were dominantly inherited with heterozygous loss‐of‐function variants, intragenic or whole gene deletions with the exception of very few de novo missense variants in the <italic>ARID1B</italic> (Bögershausen &amp; Wollnik, <xref ref-type="ref" rid="mgg31006-bib-0003">2018</xref>). The NC_000006.12 (NM_020732.3): c.5025+2T&gt;C variant of <italic>ARID1B</italic> detected in our patient was predicted to be probably pathogenic by Mutation Taster and the Human Splicing Finder. Sanger sequencing of the patient's cDNA revealed that this variant disrupts the original 5′ splice site in intron 19, thus leading to skipping of exon 19 (Figure <xref ref-type="fig" rid="mgg31006-fig-0002">2</xref>b). Single exon skipping is a common outcome of the pathogenic pre‐mRNA splicing variant, resulting in a shift of the open reading frame, formation of a premature termination codon, and, consequently, the synthesis of shorter proteins (Anna &amp; Monika, <xref ref-type="ref" rid="mgg31006-bib-0002">2018</xref>). The presence of both wild type and abnormal transcript resulting from the c.5025+2T&gt;C variant indicated that the abnormal transcript does not undergo full nonsense‐mediated decay, but instead resulted in the production of the truncated protein NP_065783.3:p.(Thr1633Valfs*11) (Figure <xref ref-type="fig" rid="mgg31006-fig-0002">2</xref>c). The original ARID1B protein (UniProtKB: Q8NFD5) comprises 2,249 amino acids and contains two domains, the AT‐rich interaction domain ARID and the C‐terminal BAF250 domain. ARID1B truncation results in the loss of the BAF250 domain (Figure <xref ref-type="fig" rid="mgg31006-fig-0002">2</xref>d), which is part of the SWI/SNF‐like ATP‐dependent chromatin remodeling complex, which regulates gene expression. Furthermore, BAF250 could act similarly to E3 ubiquitin ligase, which targets histone H2B (Li, Trojer, Matsumura, Treisman, &amp; Tanese, <xref ref-type="ref" rid="mgg31006-bib-0011">2010</xref>). Previous studies of BAF250b knockout mouse embryonic stem cells showed that the modified cells exhibited defects in self‐renewal capacity and increased differentiation. These findings suggest that BAF250 plays an important role in the early development of an embryo (Yan et al., <xref ref-type="ref" rid="mgg31006-bib-0021">2008</xref>). ARID1B‐associated BAF complexes are involved in the neuronal differentiation and maturation processes within mammalian brains, specifically developing pyramidal neurons to generate a complex dendritic architecture (Boyer et al., <xref ref-type="ref" rid="mgg31006-bib-0005">2005</xref>; Flores‐Alcantar, Gonzalez‐Sandoval, Escalante‐Alcalde, &amp; Lomelí, <xref ref-type="ref" rid="mgg31006-bib-0006">2011</xref>; Yan et al., <xref ref-type="ref" rid="mgg31006-bib-0021">2008</xref>). It is known that haploinsufficiency of <italic>ARID1B</italic> leads to the reduction of GABAergic interneurons in the cerebral cortex, thereby affecting excitatory and inhibitory neurotransmission processes during brain development. Furthermore, it was suggested that haploinsufficiency might affect epigenetic regulation by disrupting normal histone modification processes. Studies in an <italic>Arid1b</italic> heterozygous mouse model revealed aberrant cognitive functioning and impaired social interaction, reflecting clinical features of ASD and ID (Jung et al., <xref ref-type="ref" rid="mgg31006-bib-0010">2017</xref>). In 2016, Ka et al. explained the mechanism of pathogenesis of both. The authors demonstrated that <italic>ARID1B</italic> deficiency is critical to the expression of genes that are essential for neurite growth and resulted in aberrant dendritic branching, spine formation, and synaptic transmission (Halgren et al., <xref ref-type="ref" rid="mgg31006-bib-0008">2012</xref>). Therefore, the defective differentiation of pyramidal neurons induced by ARID1B deficiency may cause ID via insufficient reception of inputs and the subsequent generation of abnormal outputs.</p>
</sec>
<sec id="mgg31006-sec-0012" sec-type="conclusions">
<label>5</label>
<title>CONCLUSIONS</title>
<p>In summary, a truncated 5′ splice site c.5025+2T&gt;C variant in <italic>ARID1B</italic> resulted in the presence of an aberrant transcript, indicating nonsense‐mediated decay avoidance and predicting the production of a truncated protein. However, further proteomic analysis to validate the presence of a truncated protein would be required. The severe clinical manifestation of our proband and loss of BAF250 domain in the ARID1B protein provided clear evidence that this pathogenic variant in exon 19 caused a frameshift in the final exon, resulting in the expression of a severe phenotype of CSS.</p>
</sec>
<sec id="mgg31006-sec-0015" sec-type="COI-statement">
<title>CONFLICT OF INTEREST</title>
<p>The authors declare that this research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="mgg31006-sec-0014">
<title>AUTHOR CONTRIBUTION</title>
<p>LP and ES performed data analysis and prepared the manuscript. LG performed WES and in silico analysis of de novo variant. ES performed functional assay and analysis of patient's cDNA sample. EP, VM, and AR contributed to conception and design of the whole experiment, and critically revised the manuscript. VK was the principal investigator.</p>
</sec>
<sec id="mgg31006-sec-0013">
<title>ETHICAL APPROVAL</title>
<p>The patient's parents provided written informed consent to publish all clinical information, including photographs of the patient in accordance with the Declaration of Helsinki.</p>
</sec>
<sec id="mgg31006-sec-0016">
<title>ACCESSION CODES</title>
<p>Sequence data have been deposited at the European Nucleotide Archive (ENA), under accession number PRJEB30505 (ERP112968).</p>
</sec>
<sec sec-type="supplementary-material">
<title>Supporting information</title>
<supplementary-material content-type="local-data" id="mgg31006-sup-0001">
<caption>
<p> </p>
</caption>
<media xlink:href="MGG3-7-e1006-s001.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
</body>
<back>
<ack id="mgg31006-sec-0017">
<title>ACKNOWLEDGMENTS</title>
<p>We extend our sincere appreciation to the patient's family for their support.</p>
</ack>
<ref-list content-type="cited-references" id="mgg31006-bibl-0001">
<title>REFERENCES</title>
<ref id="mgg31006-bib-0001">
<mixed-citation id="mgg31006-cit-0001" publication-type="journal">
<string-name>
<surname>Alfaiz</surname>, <given-names>A. A.</given-names>
</string-name>, <string-name>
<surname>Micale</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Mandriani</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Augello</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Pellico</surname>, <given-names>M. T.</given-names>
</string-name>, <string-name>
<surname>Chrast</surname>, <given-names>J.</given-names>
</string-name>, … <string-name>
<surname>Reymond</surname>, <given-names>A.</given-names>
</string-name> (<year>2014</year>). <article-title>TBC1D7 mutations are associated with intellectual disability, macrocrania, patellar dislocation, and celiac disease</article-title>. <source xml:lang="en"/>Human Mutation, <volume>35</volume>, <fpage>447</fpage>–<lpage>451</lpage>. <pub-id pub-id-type="doi">10.1002/humu.22529</pub-id>
<pub-id pub-id-type="pmid">24515783</pub-id></mixed-citation>
</ref>
<ref id="mgg31006-bib-0002">
<mixed-citation id="mgg31006-cit-0002" publication-type="journal">
<string-name>
<surname>Anna</surname>, <given-names>A.</given-names>
</string-name>, &amp; <string-name>
<surname>Monika</surname>, <given-names>G.</given-names>
</string-name> (<year>2018</year>). <article-title>Splicing mutations in human genetic disorders: Examples, detection, and confirmation</article-title>. <source xml:lang="en"/>Journal of Applied Genetics, <volume>59</volume>, <fpage>253</fpage>–<lpage>268</lpage>. <pub-id pub-id-type="doi">10.1007/s13353-018-0444-7</pub-id>
<pub-id pub-id-type="pmid">29680930</pub-id></mixed-citation>
</ref>
<ref id="mgg31006-bib-0003">
<mixed-citation id="mgg31006-cit-0003" publication-type="journal">
<string-name>
<surname>Bögershausen</surname>, <given-names>N.</given-names>
</string-name>, &amp; <string-name>
<surname>Wollnik</surname>, <given-names>B.</given-names>
</string-name> (<year>2018</year>). <article-title>Mutational landscapes and phenotypic spectrum of SWI/SNF‐related intellectual disability disorders</article-title>. <source xml:lang="en"/>Frontiers in Molecular Neuroscience, <volume>11</volume>, <fpage>252</fpage>
<pub-id pub-id-type="doi">10.3389/fnmol.2018.00252</pub-id>
<pub-id pub-id-type="pmid">30123105</pub-id></mixed-citation>
</ref>
<ref id="mgg31006-bib-0004">
<mixed-citation id="mgg31006-cit-0004" publication-type="journal">
<string-name>
<surname>Borck</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Hög</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Dentici</surname>, <given-names>M. L.</given-names>
</string-name>, <string-name>
<surname>Tan</surname>, <given-names>P. L.</given-names>
</string-name>, <string-name>
<surname>Sowada</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Medeira</surname>, <given-names>A.</given-names>
</string-name>, … <string-name>
<surname>Kubisch</surname>, <given-names>C.</given-names>
</string-name> (<year>2015</year>). <article-title>BRF1 mutations alter RNA polymerase III‐dependent transcription and cause neurodevelopmental anomalies</article-title>. <source xml:lang="en"/>Genome Research, <volume>25</volume>, <fpage>155</fpage>–<lpage>166</lpage>. <pub-id pub-id-type="doi">10.1101/gr.176925.114</pub-id>
<pub-id pub-id-type="pmid">25561519</pub-id></mixed-citation>
</ref>
<ref id="mgg31006-bib-0005">
<mixed-citation id="mgg31006-cit-0005" publication-type="journal">
<string-name>
<surname>Boyer</surname>, <given-names>L. A.</given-names>
</string-name>, <string-name>
<surname>Lee</surname>, <given-names>T. I.</given-names>
</string-name>, <string-name>
<surname>Cole</surname>, <given-names>M. F.</given-names>
</string-name>, <string-name>
<surname>Johnstone</surname>, <given-names>S. E.</given-names>
</string-name>, <string-name>
<surname>Levine</surname>, <given-names>S. S.</given-names>
</string-name>, <string-name>
<surname>Zucker</surname>, <given-names>J. P.</given-names>
</string-name>, … <string-name>
<surname>Young</surname>, <given-names>R. A.</given-names>
</string-name> (<year>2005</year>). <article-title>Core transcriptional regulatory circuitry in human embryonic stem cells</article-title>. <source xml:lang="en"/>Cell, <volume>122</volume>, <fpage>947</fpage>–<lpage>956</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2005.08.020</pub-id>
<pub-id pub-id-type="pmid">16153702</pub-id></mixed-citation>
</ref>
<ref id="mgg31006-bib-0006">
<mixed-citation id="mgg31006-cit-0006" publication-type="journal">
<string-name>
<surname>Flores‐Alcantar</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Gonzalez‐Sandoval</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Escalante‐Alcalde</surname>, <given-names>D.</given-names>
</string-name>, &amp; <string-name>
<surname>Lomelí</surname>, <given-names>H.</given-names>
</string-name> (<year>2011</year>). <article-title>Dynamics of expression of ARID1A and ARID1B subunits in mouse embryos and in cells during the cell cycle</article-title>. <source xml:lang="en"/>Cell and Tissue Research, <volume>345</volume>, <fpage>137</fpage>–<lpage>148</lpage>. <pub-id pub-id-type="doi">10.1007/s00441-011-1182-x</pub-id>
<pub-id pub-id-type="pmid">21647563</pub-id></mixed-citation>
</ref>
<ref id="mgg31006-bib-0007">
<mixed-citation id="mgg31006-cit-0007" publication-type="journal">
<string-name>
<surname>Gueneau</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Fish</surname>, <given-names>R. J.</given-names>
</string-name>, <string-name>
<surname>Shamseldin</surname>, <given-names>H. E.</given-names>
</string-name>, <string-name>
<surname>Voisin</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Tran Mau‐Them</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Preiksaitiene</surname>, <given-names>E.</given-names>
</string-name>, … <string-name>
<surname>Reymond</surname>, <given-names>A.</given-names>
</string-name> (<year>2018</year>). <article-title>KIAA1109 variants are associated with a severe disorder of brain development and arthrogryposis</article-title>. <source xml:lang="en"/>American Journal of Human Genetics, <volume>102</volume>, <fpage>116</fpage>–<lpage>132</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2017.12.002</pub-id>
<pub-id pub-id-type="pmid">29290337</pub-id></mixed-citation>
</ref>
<ref id="mgg31006-bib-0008">
<mixed-citation id="mgg31006-cit-0008" publication-type="journal">
<string-name>
<surname>Halgren</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Kjaergaard</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Bak</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Hansen</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>El‐Schich</surname>, <given-names>Z.</given-names>
</string-name>, <string-name>
<surname>Anderson</surname>, <given-names>C. M.</given-names>
</string-name>, … <string-name>
<surname>Bache</surname>, <given-names>I.</given-names>
</string-name> (<year>2012</year>). <article-title>Corpus callosum abnormalities, intellectual disability, speech impairment, and autism in patients with haploinsufficiency of ARID1B</article-title>. <source xml:lang="en"/>Clinical Genetics, <volume>82</volume>, <fpage>248</fpage>–<lpage>255</lpage>. <pub-id pub-id-type="doi">10.1111/j.1399-0004.2011.01755.x</pub-id>
<pub-id pub-id-type="pmid">21801163</pub-id></mixed-citation>
</ref>
<ref id="mgg31006-bib-0009">
<mixed-citation id="mgg31006-cit-0009" publication-type="journal">
<string-name>
<surname>Hoyer</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Ekici</surname>, <given-names>A. B.</given-names>
</string-name>, <string-name>
<surname>Endele</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Popp</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Zweier</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Wiesener</surname>, <given-names>A.</given-names>
</string-name>, … <string-name>
<surname>Reis</surname>, <given-names>A.</given-names>
</string-name> (<year>2012</year>). <article-title>Haploinsufficiency of ARID1B, a member of the SWI/SNF‐A chromatin‐remodeling complex, is a frequent cause of intellectual disability</article-title>. <source xml:lang="en"/>American Journal of Human Genetics, <volume>90</volume>, <fpage>565</fpage>–<lpage>572</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2012.02.007</pub-id>
<pub-id pub-id-type="pmid">22405089</pub-id></mixed-citation>
</ref>
<ref id="mgg31006-bib-0010">
<mixed-citation id="mgg31006-cit-0010" publication-type="journal">
<string-name>
<surname>Jung</surname>, <given-names>E. M.</given-names>
</string-name>, <string-name>
<surname>Moffat</surname>, <given-names>J. J.</given-names>
</string-name>, <string-name>
<surname>Liu</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Dravid</surname>, <given-names>S. M.</given-names>
</string-name>, <string-name>
<surname>Gurumurthy</surname>, <given-names>C. B.</given-names>
</string-name>, &amp; <string-name>
<surname>Kim</surname>, <given-names>W. Y.</given-names>
</string-name> (<year>2017</year>). <article-title>Arid1b haploinsufficiency disrupts cortical interneuron development and mouse behavior</article-title>. <source xml:lang="en"/>Nature Neuroscience, <volume>20</volume>, <fpage>1694</fpage>–<lpage>1707</lpage>. <pub-id pub-id-type="doi">10.1038/s41593-017-0013-0</pub-id>
<pub-id pub-id-type="pmid">29184203</pub-id></mixed-citation>
</ref>
<ref id="mgg31006-bib-0011">
<mixed-citation id="mgg31006-cit-0011" publication-type="journal">
<string-name>
<surname>Li</surname>, <given-names>X. S.</given-names>
</string-name>, <string-name>
<surname>Trojer</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Matsumura</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Treisman</surname>, <given-names>J. E.</given-names>
</string-name>, &amp; <string-name>
<surname>Tanese</surname>, <given-names>N.</given-names>
</string-name> (<year>2010</year>). <article-title>Mammalian SWI/SNF‐A subunit BAF250/ARID1 is an E3 ubiquitin ligase that targets histone H2B</article-title>. <source xml:lang="en"/>Molecular and Cellular Biology, <volume>30</volume>, <fpage>1673</fpage>–<lpage>1688</lpage>. <pub-id pub-id-type="doi">10.1128/mcb.00540-09</pub-id>
<pub-id pub-id-type="pmid">20086098</pub-id></mixed-citation>
</ref>
<ref id="mgg31006-bib-0012">
<mixed-citation id="mgg31006-cit-0012" publication-type="journal">
<string-name>
<surname>Lodder</surname>, <given-names>E. M.</given-names>
</string-name>, <string-name>
<surname>De Nittis</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Koopman</surname>, <given-names>C. D.</given-names>
</string-name>, <string-name>
<surname>Wiszniewski</surname>, <given-names>W.</given-names>
</string-name>, <string-name>
<surname>Moura de Souza</surname>, <given-names>C. F.</given-names>
</string-name>, <string-name>
<surname>Lahrouchi</surname>, <given-names>N.</given-names>
</string-name>, … <string-name>
<surname>Merla</surname>, <given-names>G.</given-names>
</string-name> (<year>2016</year>). <article-title>GNB5 mutations cause an Autosomal‐Recessive Multisystem syndrome with Sinus Bradycardia and cognitive disability</article-title>. <source xml:lang="en"/>American Journal of Human Genetics, <volume>99</volume>, <fpage>704</fpage>–<lpage>710</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2016.06.025</pub-id>
<pub-id pub-id-type="pmid">27523599</pub-id></mixed-citation>
</ref>
<ref id="mgg31006-bib-0013">
<mixed-citation id="mgg31006-cit-0013" publication-type="journal">
<string-name>
<surname>Pranckeniene</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Jakaitiene</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Ambrozaityte</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Kavaliauskiene</surname>, <given-names>I.</given-names>
</string-name>, &amp; <string-name>
<surname>Kučinskas</surname>, <given-names>V.</given-names>
</string-name> (<year>2018</year>). <article-title>Insights into de novo mutation variation in Lithuanian exome</article-title>. <source xml:lang="en"/>Frontiers in Genetics, <volume>9</volume>, <fpage>315</fpage>
<pub-id pub-id-type="doi">10.3389/fgene.2018.00315</pub-id>
<pub-id pub-id-type="pmid">30154829</pub-id></mixed-citation>
</ref>
<ref id="mgg31006-bib-0014">
<mixed-citation id="mgg31006-cit-0014" publication-type="journal">
<string-name>
<surname>Santen</surname>, <given-names>G. W. E.</given-names>
</string-name>, <string-name>
<surname>Aten</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Sun</surname>, <given-names>Y. U.</given-names>
</string-name>, <string-name>
<surname>Almomani</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Gilissen</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Nielsen</surname>, <given-names>M.</given-names>
</string-name>, … <string-name>
<surname>Kriek</surname>, <given-names>M.</given-names>
</string-name> (<year>2012</year>). <article-title>Mutations in SWI/SNF chromatin remodeling complex gene ARID1B cause Coffin‐Siris syndrome</article-title>. <source xml:lang="en"/>Nature Genetics, <volume>44</volume>, <fpage>379</fpage>–<lpage>380</lpage>. <pub-id pub-id-type="doi">10.1038/ng.2217</pub-id>
<pub-id pub-id-type="pmid">22426309</pub-id></mixed-citation>
</ref>
<ref id="mgg31006-bib-0015">
<mixed-citation id="mgg31006-cit-0015" publication-type="journal">
<string-name>
<surname>Santen</surname>, <given-names>G. W. E.</given-names>
</string-name>, <string-name>
<surname>Aten</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Vulto‐van Silfhout</surname>, <given-names>A. T.</given-names>
</string-name>, <string-name>
<surname>Pottinger</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>van Bon</surname>, <given-names>B. W. M.</given-names>
</string-name>, <string-name>
<surname>van Minderhout</surname>, <given-names>I. J. H. M.</given-names>
</string-name>, … <string-name>
<surname>Yesil</surname>, <given-names>G.</given-names>
</string-name> (<year>2013</year>). <article-title>Coffin‐Siris syndrome and the BAF complex: Genotype‐phenotype study in 63 patients</article-title>. <source xml:lang="en"/>Human Mutation, <volume>34</volume>, <fpage>1519</fpage>–<lpage>1528</lpage>. <pub-id pub-id-type="doi">10.1002/humu.22394</pub-id>
<pub-id pub-id-type="pmid">23929686</pub-id></mixed-citation>
</ref>
<ref id="mgg31006-bib-0016">
<mixed-citation id="mgg31006-cit-0016" publication-type="journal">
<string-name>
<surname>Tumienė</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Voisin</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Preikšaitienė</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Petroška</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Grikinienė</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Samaitienė</surname>, <given-names>R.</given-names>
</string-name>, … <string-name>
<surname>Kučinskas</surname>, <given-names>V.</given-names>
</string-name> (<year>2017</year>). <article-title>Inflammatory myopathy in a patient with Aicardi‐Goutières syndrome</article-title>. <source xml:lang="en"/>European Journal of Medical Genetics, <volume>60</volume>, <fpage>154</fpage>–<lpage>158</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmg.2016.12.004</pub-id>
<pub-id pub-id-type="pmid">28089741</pub-id></mixed-citation>
</ref>
<ref id="mgg31006-bib-0017">
<mixed-citation id="mgg31006-cit-0017" publication-type="journal">
<string-name>
<surname>Van der Auwera</surname>, <given-names>G. A.</given-names>
</string-name>, <string-name>
<surname>Carneiro</surname>, <given-names>M. O.</given-names>
</string-name>, <string-name>
<surname>Hartl</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Poplin</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>del Angel</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Levy‐Moonshine</surname>, <given-names>A.</given-names>
</string-name>, … <string-name>
<surname>DePristo</surname>, <given-names>M. A.</given-names>
</string-name> (<year>2013</year>). <article-title>From fastQ data to high‐confidence variant calls: The genome analysis toolkit best practices pipeline</article-title>. <source xml:lang="en"/>Current Protocols in Bioinformatics, <volume>43</volume>, <fpage>11.10.1</fpage>–<lpage>11.10.33</lpage>. <pub-id pub-id-type="doi">10.1002/0471250953.bi1110s43</pub-id>
<pub-id pub-id-type="pmid">25431634</pub-id></mixed-citation>
</ref>
<ref id="mgg31006-bib-0018">
<mixed-citation id="mgg31006-cit-0018" publication-type="journal">
<string-name>
<surname>van der Sluijs</surname>, <given-names>P. J.</given-names>
</string-name>, <string-name>
<surname>Jansen</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Vergano</surname>, <given-names>S. A.</given-names>
</string-name>, <string-name>
<surname>Adachi‐Fukuda</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Alanay</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>AlKindy</surname>, <given-names>A.</given-names>
</string-name>, … <string-name>
<surname>Santen</surname>, <given-names>G. W. E.</given-names>
</string-name> (<year>2018</year>). <article-title>The ARID1B spectrum in 143 patients: From nonsyndromic intellectual disability to Coffin‐Siris syndrome</article-title>. <source xml:lang="en"/>Genetics in Medicine, <volume>21</volume>, <fpage>1295</fpage>–<lpage>1307</lpage>. <pub-id pub-id-type="doi">10.1038/s41436-018-0330-z</pub-id>
<pub-id pub-id-type="pmid">30349098</pub-id></mixed-citation>
</ref>
<ref id="mgg31006-bib-0019">
<mixed-citation id="mgg31006-cit-0019" publication-type="journal">
<string-name>
<surname>Vasileiou</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Ekici</surname>, <given-names>A. B.</given-names>
</string-name>, <string-name>
<surname>Uebe</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Zweier</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Hoyer</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Engels</surname>, <given-names>H.</given-names>
</string-name>, … <string-name>
<surname>Hadjihannas</surname>, <given-names>M. V.</given-names>
</string-name> (<year>2015</year>). <article-title>Chromatin‐remodeling‐factor ARID1B represses Wnt/β‐catenin signaling</article-title>. <source xml:lang="en"/>American Journal of Human Genetics, <volume>97</volume>, <fpage>445</fpage>–<lpage>456</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2015.08.002</pub-id>
<pub-id pub-id-type="pmid">26340334</pub-id></mixed-citation>
</ref>
<ref id="mgg31006-bib-0020">
<mixed-citation id="mgg31006-cit-0020" publication-type="journal">
<string-name>
<surname>Wieczorek</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Bögershausen</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Beleggia</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Steiner‐Haldenstätt</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Pohl</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Li</surname>, <given-names>Y.</given-names>
</string-name>, … <string-name>
<surname>Wollnik</surname>, <given-names>B.</given-names>
</string-name> (<year>2013</year>). <article-title>A comprehensive molecular study on coffin‐siris and nicolaides‐baraitser syndromes identifies a broad molecular and clinical spectrum converging on altered chromatin remodeling</article-title>. <source xml:lang="en"/>Human Molecular Genetics, <volume>22</volume>, <fpage>5121</fpage>–<lpage>5135</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddt366</pub-id>
<pub-id pub-id-type="pmid">23906836</pub-id></mixed-citation>
</ref>
<ref id="mgg31006-bib-0021">
<mixed-citation id="mgg31006-cit-0021" publication-type="journal">
<string-name>
<surname>Yan</surname>, <given-names>Z.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>, <given-names>Z.</given-names>
</string-name>, <string-name>
<surname>Sharova</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Sharov</surname>, <given-names>A. A.</given-names>
</string-name>, <string-name>
<surname>Ling</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Piao</surname>, <given-names>Y.</given-names>
</string-name>, … <string-name>
<surname>Ko</surname>, <given-names>M. S. H.</given-names>
</string-name> (<year>2008</year>). <article-title>BAF250B‐associated SWI/SNF chromatin‐remodeling complex is required to maintain undifferentiated mouse embryonic stem cells</article-title>. <source xml:lang="en"/>Stem Cells, <volume>26</volume>, <fpage>1155</fpage>–<lpage>1165</lpage>. <pub-id pub-id-type="doi">10.1634/stemcells.2007-0846</pub-id>
<pub-id pub-id-type="pmid">18323406</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>